Stamaril

• Prophylaxis of Yellow fever infection
• Travelling to, passing through or living in an area where yellow fever occurs
• Travelling to any country that requires an International Certificate of Vaccination for entry
• Laboratory workers who may handle infectious materials

Adult Dose (SC):

• Primary Vaccination: 0.5 ml, given as SC inj (preferably into the deltoid area) as a single dose, at least 10 days prior to travel
• Booster dose: Repeat dose every 10 yr for those at continued risk of exposure

Child Dose (>9 months) (SC):

• 0.5 ml, given as SC inj (preferably into the deltoid area for children >3 yr and thigh area for children <3 yr), at least 10 days prior to travel
• Booster dose: Repeat dose every 10 yr

Common Side Effects:

• Headache (5-10%)
• Chills (5-10%)
• Low-grade fever (5-10%)
• Myalgia (5-10%)
• Meningoencephalitis
• Seizures
• Rash
• Urticaria
• Pain
• Warmth
• Erythema
• Guillain-Barre syndrome

Use in Pregnancy: Should not receive Yellow Fever Vaccine during pregnancy unless this cannot be avoided.

• Caution when used in immunocompromised patients
• Increased risk of adverse effects when used in patients ≥65 yr
• Monitor for adverse events 10-30 days post-vaccination
• Pregnancy
• Lactation is a contraindication, particularly when infants are <9 months of age

Symptoms: Limited information.

Treatment: Supportive care.